<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Brainstorm Cell Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Brainstorm Cell Therapeutics Inc.

    BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Chaim Lebovits
    • FOUNDED
      2004
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Forty Seven, Inc.

    Forty Seven, Inc.

    Forty Seven is a clinical-stage immuno-oncology company focused on developing nove...

    Forty Seven is a clinical-stage immuno-oncology...

    Filing Type:    PU
    China Biologic Products Holdings, Inc.

    China Biologic Products Holdings, Inc.

    China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrat...

    China Biologic Products Holdings, Inc. (NASDAQ:...

    Filing Type:    PU
    DelMar Pharmaceuticals, Inc.

    DelMar Pharmaceuticals, Inc.

    DelMar Pharmaceuticals is a biopharmaceutical company focused on the development a...

    DelMar Pharmaceuticals is a biopharmaceutical c...

    Filing Type:    PU
    Illusio, Inc.

    Illusio, Inc.

    ILLUSIO is a plastic surgery simulation tool that enables a surgeon and patient to...

    ILLUSIO is a plastic surgery simulation tool th...

    Fundraising Status:    EC
    Filing Type:    CF
    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    ViewRay, Inc.

    ViewRay, Inc.

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdianÂŽ the wor...

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufac...

    Filing Type:    PU
    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental...

    Pluristem Therapeutics Inc. is a clinical-stage...

    Filing Type:    PU
    Fibrocell Science Inc.

    Fibrocell Science Inc.

    Fibrocell is a cell and gene therapy company focused on improving the lives of peo...

    Fibrocell is a cell and gene therapy company fo...

    Filing Type:    PU
    BioCardia, Inc.

    BioCardia, Inc.

    BioCardia, Inc., headquartered in San Carlos, California, is developing regenerati...

    BioCardia, Inc., headquartered in San Carlos, C...

    Filing Type:    PU
    Alterity Therapeutics Limited

    Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative di...

    We exist to create an alternate future for peop...

    Filing Type:    PU
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.